Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|December 9, 2024
Divulging the potency of naturally derived photosensitizers in green PDT: an inclusive review Of mechanisms, advantages, and future prospectsMuskan Gupta, Anwesha Sahu, Tuhin Mukherjee, et al.
Frontiers in Genetics|November 26, 2025
Germline activating sequence variations in RASopathy spectrum genes: genotype-phenotype correlation in a North Indian cohortShifali Gupta, Priyanka Srivastava, Roshan Daniel, et al.
Current Drug Metabolism|September 15, 2025
Advances in Nanomedicine: Transforming Diagnostic Imaging with Novel Contrast AgentsPriyamjeet Das, Muskan Gupta, Anwesha Sahu, et al.
Journal of Medicinal Chemistry|February 15, 2023
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier InhibitionAntonio Laghezza, Carmen Cerchia, Massimo Genovese, et al.
Plants (Basel, Switzerland)|March 29, 2023
Marker-Assisted Improvement for Durable Bacterial Blight Resistance in Aromatic Rice Cultivar HUR 917 Popular in Eastern Parts of IndiaManish Kumar, Ravi Pratap Singh, Debarchana Jena, et al.
European Journal of Medicinal Chemistry|March 15, 2025
A new potent and selective peroxisome proliferator-activated receptor alpha partial agonist displays anti-steatotic effects In vitro and behaves as a safe hypolipidemic and hypoglycemic agent in a diabetic mouse modelAntonio Laghezza, Emanuele Falbo, Federica Gilardi, et al.
Chemmedchem|October 8, 2020
A Series of Ferulic Acid Amides Reveals Unexpected Peroxiredoxin 1 Inhibitory Activity with in vivo Antidiabetic and Hypolipidemic EffectsSabina Yasmin, Carmen Cerchia, Vishnu Nayak Badavath, et al.
European Journal of Medicinal Chemistry|June 12, 2024
A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic propertiesAntonio Laghezza, Carmen Cerchia, Massimo Genovese, et al.
Pageof 4